The obstetric antiphospholipid syndrome

被引:36
作者
Derksen, R. H. W. M. [1 ]
de Grootb, Ph. G. [2 ]
机构
[1] Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands
[2] Univ Med Ctr, Thrombosis & Haemostasis Lab, Dept Clin Chem & Haematol, Utrecht, Netherlands
关键词
antiphospholipid syndrome; lupus anticogulans; anticardiolipin antibodies; recurrent pregnancy loss; fetal loss; RECURRENT PREGNANCY LOSS; LOW-DOSE ASPIRIN; INTERNATIONAL CONSENSUS STATEMENT; GLYCOPROTEIN-I ANTIBODIES; MOLECULAR-WEIGHT HEPARIN; LUPUS ANTICOAGULANT; ANTICARDIOLIPIN ANTIBODIES; FETAL LOSS; CLASSIFICATION CRITERIA; CONTROLLED-TRIAL;
D O I
10.1016/j.jri.2006.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The association of persistent presence of circulating antiphospholipid antibodies and thromboembolic events, (recurrent) pregnancy loss or both is termed antiphospholipid syndrome. Pregnancies in women with the syndrome should be regarded as at high-risk for complications. Optimal management consisting of close follow-up and pharmacological treatment can result in about 70-80% live births. Apart from the laboratory diagnosis of the syndrome and pathophysiology, this review will focus on treatment during pregnancy. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:41 / 50
页数:10
相关论文
共 70 条
[1]   Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin [J].
Backos, M ;
Rai, R ;
Baxter, N ;
Chilcott, IT ;
Cohen, H ;
Regan, L .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (02) :102-107
[2]   LOW-DOSE ASPIRIN FOR PREVENTION OF PREGNANCY LOSSES IN WOMEN WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME [J].
BALASCH, J ;
CARMONA, F ;
LOPEZSOTO, A ;
FONT, J ;
CREUS, M ;
FABREGUES, F ;
INGELMO, M ;
VANRELL, JA .
HUMAN REPRODUCTION, 1993, 8 (12) :2234-2239
[3]   Use of antithrombotic agents during pregnancy [J].
Bates, SA ;
Greer, IA ;
Hirsh, J ;
Ginsberg, JS .
CHEST, 2004, 126 (03) :627S-644S
[4]   Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro [J].
Bose, P ;
Black, S ;
Kadyrov, M ;
Bartz, C ;
Shlebak, A ;
Regan, L ;
Huppertz, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (06) :2125-2131
[5]   Antiphospholipid syndrome: Obstetric diagnosis, management, and controversies [J].
Branch, DW ;
Khamashta, MA .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (06) :1333-1344
[6]  
BRANCH DW, 1992, OBSTET GYNECOL, V80, P614
[7]   A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy [J].
Branch, DW ;
Peaceman, AM ;
Druzin, M ;
Silver, RK ;
El-Sayed, Y ;
Silver, RM ;
Esplin, MS ;
Spinnato, J ;
Harger, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (01) :122-127
[8]  
Brandt JT, 1995, THROMB HAEMOSTASIS, V74, P1597
[9]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[10]   Future pregnancy outcome in unexplained recurrent first trimester miscarriage [J].
Clifford, K ;
Rai, R ;
Regan, L .
HUMAN REPRODUCTION, 1997, 12 (02) :387-389